MABTHERA 500MG (RITUXIMAB) – TARGETED BIOLOGICAL THERAPY

Description: MabThera contains Rituximab (500mg), a genetically engineered chimeric monoclonal antibody. It is a highly specialized biological medication that specifically targets and binds to the CD20 protein found on the surface of B-lymphocytes (a type of white blood cell). Once attached, MabThera triggers the body's immune system to attack and destroy these specific B-cells. This precise action makes it a powerful treatment for various conditions where overactive or cancerous B-cells are the underlying cause.

In Nigeria, MabThera is a critical clinical intervention for oncology and autoimmune disorders. It is available through premier tertiary health providers and authorized distributors like Sanlive Pharmacy, ensuring you receive a genuine, cold-chain managed medication. Because this is a high-sensitivity biological drug, it must be stored between 2°C and 8°C at all times to maintain its molecular structure and therapeutic efficacy.

Important: MabThera is a prescription-only medication that must be administered as an intravenous (IV) infusion by trained healthcare professionals in a hospital or clinic setting. It is not for self-administration. Before starting treatment, patients must be screened for Hepatitis B, as the drug can cause the virus to reactivate.

Key Uses & Benefits

MabThera 500mg is primarily used to treat:

• Non-Hodgkin’s Lymphoma (NHL): Targeted destruction of cancerous B-cells in various forms of the disease

• Chronic Lymphocytic Leukemia (CLL): Used in combination with chemotherapy for better patient outcomes

• Rheumatoid Arthritis (RA): Reduces joint damage and inflammation in patients who have not responded to other therapies

• Granulomatosis with Polyangiitis (GPA) and MPA: Rare autoimmune diseases involving inflammation of blood vessels

• Pemphigus Vulgaris: A severe autoimmune condition causing blisters on the skin and mucous membranes

Who Should Receive MabThera?

This product is suitable for:

• Adults with specific types of blood cancers (B-cell malignancies)

• Adults with severe autoimmune conditions unresponsive to standard DMARDs

• Pediatric patients (in specific cases for GPA/MPA under strict specialist guidance)

Not recommended for: Individuals with active, severe infections or a severely weakened immune system. It is contraindicated in patients with a known hypersensitivity to rituximab or murine (mouse) proteins. Use in pregnant or breastfeeding women should only occur if the benefit strictly outweighs the risk, as it can deplete B-cells in the fetus.

Suggested Usage & Administration:

• Clinical Setting: Must be administered via intravenous infusion in a facility equipped for resuscitation

• Pre-medication: Patients are typically given an analgesic (paracetamol), an antihistamine, and sometimes a steroid before the infusion to reduce the risk of infusion-related reactions

• Infusion Speed: The first infusion is given slowly; if well-tolerated, subsequent doses may be administered more quickly

• Monitoring: Vital signs (blood pressure, heart rate, breathing) are monitored closely throughout the procedure and for several hours afterward

• Dosing Schedule: Varies significantly based on the condition being treated; your oncologist or rheumatologist will determine your specific cycle

Common Side Effects

Side effects often occur during or shortly after the infusion:

• Infusion Reactions: Fever, chills, shaking, itching, or rash (most common during the first dose)

• General: Fatigue, headache, and nausea

• Hematological: Low white blood cell counts (neutropenia), increasing the risk of infections

• Occasional: Aching muscles or joints and localized swelling

• Serious: Seek immediate medical help for breathing difficulties, chest pain, or a severe peeling skin rash (Stevens-Johnson syndrome)

Manufacturer

Roche (Genentech) – A global leader in biotechnology and oncology, recognized for developing the original, high-purity Rituximab (MabThera/Rituxan) used in international clinical protocols.

Why Source MabThera from Sanlive Pharmacy?

• 100% Cold-Chain Integrity: We guarantee the medication has been kept between 2°C and 8°C from the manufacturer to your hands

• Verified Authenticity: Sourced exclusively from authorized Roche distributors to eliminate the risk of counterfeit biologics

• Specialist Coordination: We work with your oncology or rheumatology clinic to ensure the medication is delivered safely for your appointment

• Professional Guidance: Access to pharmacists for advice on managing post-infusion symptoms and immune health

Frequently Asked Questions (FAQs)

How long does an infusion take?

The first infusion can take 4 to 6 hours as it is administered very slowly to check for reactions. Subsequent infusions are often faster, typically lasting 2 to 3 hours.

Will it affect my immune system?

Yes. Because MabThera removes B-cells, your body may be less able to fight off infections for several months after treatment. It is recommended to avoid live vaccines during this period.

Why do I need a Hepatitis B test first?

Rituximab can cause a dormant Hepatitis B infection to become active again, which can lead to serious liver failure. If you test positive, your doctor may prescribe antiviral medicine to protect your liver during treatment.

Where can I buy authentic MabThera 500mg in Nigeria?

You can fulfill your prescription for MabThera (Rituximab) through Sanlive Pharmacy & Stores for guaranteed quality, cold-chain security, and professional pharmaceutical support.